Imidazoline receptors and human brain disorders

Annals of the New York Academy of Sciences

Volumn 881, Issue , 1999, Pages 392-409

  García Sevilla, Jesús A ^a,b   Escribá, Pablo V ^a   Guimón, José ^b  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

IDAZOXAN; IMIDAZOLINE RECEPTOR; OPIATE;

ALZHEIMER DISEASE; CONFERENCE PAPER; DEPRESSION; DOWN REGULATION; GLIOMA; HUMAN; HUNTINGTON CHOREA; NERVE DEGENERATION; OPIATE ADDICTION; RECEPTOR DENSITY; SUICIDE; THROMBOCYTE;

EID: 0032787465     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb09388.x     Document Type: Conference Paper

References (45)

1. 2 sites in the mammalian central nervous system. Pharmacol. Ther. 68: 175-208.
2. Regunathan, S. & D. J. Reis. 1996, Imidazoline receptors and their endogenous ligands. Annu. Rev. Pharmacol. 36: 511-544.
3. Molderings, G. J. 1997. Imidazoline receptors: Basic knowledge, recent advances and future prospects for therapy and diagnosis. Drugs Fut. 22: 757-772.
4. Escribá, P. V., M. Sastre, H. Wang, S. Regunathan, D. J. & J. A. García-Sevilla. 1994. Immunodetection of putative imidazoline receptor proteins in the human and rat brain and other tissues. Neurosci. Lett. 178: 81-84.
5. Ivanov, T. R., H. Zhu, S. Regunathan, D. J. Reis, M. Dontenwill, C. Vonthron, P. Bousquet & J. E. Piletz. 1998. Co-detection by two imidazoline receptor protein antisera of a novel 85 kilodalton protein. Biochem. Pharmacol. 55: 649-655.
6. Parini, A., C. G. Moudanos, N. Pizzinat & S. M. Lanier. 1996. The elusive family of imidazoline binding sites. Trends Pharmacol. Sci. 17: 13-16.
7. 3H]RX821002 (2-methoxy idazoxan) in the human and rat brains. J. Pharmacol. Exp. Ther. 264: 1187-1197.
8. 2-adrenoceptors in the human central nervous system. Neuroscience 59: 589-598.
9. 3H]-rauwolscine. Brain Res. 566: 13-20.
10. Ruggiero, D. A., S. Regunathan, H. Wang, T. A. Milner & D. J. Ries. 1998. Immunocytochemical localization of an imidazoline receptor protein in the central nervous system. Brain Res. 780: 270-293.
11. García-Sevilla, J. A., P. V. Escribá, M. Sastre, C. Walter, X. Busquets, G. Jaquet, D.J. Reis & J. Guimón. 1996. Immunodetection and quantitation of imidazoline receptor proteins in platelets of patients with major depression and in brains of suicide victims. Arch. Gen. Psychiatry 53: 803-810.
12. 2-adrenoceptors and monoamine oxidase B in brains of suicide victims. Neurochem. Int. 30: 63-72.
13. Escribá, P. V., A. Ozaita, A. Miralles, D. J. Reis & J. A. García-Sevilla. 1995. Molecular characterization and isolation of a 45-kilodalton imidazoline receptor protein from the rat brain. Mol. Brain Res. 32: 187-196.
14. Bennai, F., H. Greney, C. Vonthron, P. Bousquet & M. Dontenwill. 1996. Polyclonal anti-idiotypic antibodies to idazoxan and their interaction with human brain imidazoline binding sites. Eur. J. Pharmacol. 306: 211-218.
15. Halaris, A. &, J. E. Piletz. 1998. Platelet imidazoline binding sites: A marker for depression?. Collegium Internationale NeuroPsychopharmacologicum (XXIst CINP Congress, Glasgow) [abstr.].
16. Piletz, J. E., A. Halaris & P. R. Ernsberger. 1995. Psychopharmacology of imidazoline and alpha-2 adrenergic receptors: Implications for depression, Crit. Rev, Neurobiol. 9: 29-66.
17. García-Sevilla, J. A., P. V. Escribá, A. Ozaita, C. Walzer & J. Guimón. 1998. Density of imidazoline receptors in platelets of euthymic patients with bipolar affective disorder and in brains of lithium-treated rats. Biol. Psychiatry 43: 616-618.
18. 3H]idazoxan. Neurosci. Lett. 184: 133-136.
19. 2-adrenoceptor states plus a non-adrenergic site on human platelet plasma membranes. Biochem. Pharmacol. 42: 569-584.
20. Piletz, J. E. & K. Sletten, 1993. Nonadrenergic imidazoline binding sites on human platelets. J. Pharmacol. Exp. Ther. 267: 1493-1502.
21. 3H]-p-aminoclonidinc binding to platelet purified plasma membranes from depressed patients. Neuropsycho-pharmacology 3: 201-210.
22. 1-imidazoline binding sites are elevated in depression but not generalized anxiety disorder. J. Psychiat. Res. 30: 147-168.
23. 1-imidazoline binding sites are decreased by two dissimilar antidepressant agents in depressed patients. J. Psychiat. Res. 30: 169-184.
24. 1imidazoline receptors to diacylglyceride accumulation in PCI2 rat pheochromocytoma cells. Mol. Pharmacol. 49: 668-675.
25. 1-imidazoline receptors. Br. J. Pharmacol. 120: 1575-1581.
26. García-Sevilla, J. A., P. V. Escribá, X. Busquets, C. Walzer & J. Guimón. 1996. Platelet imidazoline receptors and regulatory G proteins in patients with major depression. NeuroReport 8: 169-172.
27. 1-imidazoline receptors in rat brainstem. Life Sci. 61: 1973-1983.
28. 2-imidazoline receptive sites in rat brain. Neurochem. Int. 30: 101-107.
29. 3H]-idazoxan binding sites in the rat brain. Br. J. Pharmacol. 108: 597-603.
30. 2 imidazoline-preferring receptors. Br. J. Pharmacol. 114: 837-845.
31. 3H]-idazoxan binding sites. Br. J. Pharmacol. 118: 2029-2036.
32. Nutt, D. J., N. French, S. Handley, A. Hudson, L. Husband, H. Jackson, S. Jordan, M. Lalies, J. Lewis, L. Lione, N. Mallard & J. Pratt. 1995. Functional studies of specific imidazoline receptor ligands. Ann. N.Y. Acad. Sci. 763: 125-139.
33. 2 ligands in forced swim test in mice [abstr.]. Br. J. Pharmacol. 122: 168P.
34. Kolesnikov, Y., S. Jain & G. W. Pasternak. 1996. Modulation of opioid analgesia by agmatine. Eur. J. Pharmacol. 296: 17-22.
35. 2-imidazoline ligands. Br. J. Pharmacol. 125: 175-185.
36. 2-imidazoline receptors in the postmortem brains of heroin addicts. NeuroReport 7: 509-512.
37. Hudson, A. L., D. J. Nutt, C. L. Barton & P. H. Hutson. 1996. 72 Hour morphine treatment decreases the density of imidazoline-2 sites in rat brain [abstr.]. J. Psychopharmacol. 10: A11/43.
38. Olmos, G., R. Alemany, P. V. Escribá & J. A. García-Sevilla. 1994. The effects of chronic imidazoline drug treatment on glial fibrillary acidic protein concentrations in rat brain. Br. J. Pharmacol. 111: 997-1002.
39. Saura, J., J. M. Luque, A. M. Cesura, M. Da Prada, V. Chan-Palay, G. Huber, J. Löffler & J. G. Richards. 1994. Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. Neuroscience 62: 15-30.
40. 2 with monoamine oxidase-B sites. J. Neurochem. 61: 881-889.
41. García-Sevilla, J. A., P. V. Escribá, C. Walzer, C. Bouras & J. Guimón. 1998. Imidazoline receptor proteins in brains of patients with Alzheimer's disease. Neurosci. Lett. 247: 95-98.
42. 2-imidazoline sites) are increased in postmortem brain from patients with Alzheimer's disease. Neurosci. Lett. 160: 109-112.
43. 2-Imidazoline binding sites and monoamine oxidase activity in human postmortem brain from patients with Parkinson's disease. Neurochem. Int. 30: 31-36.
44. Reynolds, G. P., R. M. Boulton, S. J. Pearson, A. L. Hudson & D. J. Nutt. 1996. Imidazoline binding sites in Huntington's and Parkinson's disease putamen. Eur. J. Pharmacol. 301: R19-R21.
45. 2-imidazoline receptors in human glioblastomas. NeuroReport 7: 1393-1396.